{"id":15511,"date":"2019-07-02T19:11:02","date_gmt":"2019-07-02T19:11:02","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=15511"},"modified":"2020-03-04T19:31:14","modified_gmt":"2020-03-04T19:31:14","slug":"cannabis-use-and-incidence-of-testicular-cancer-a-42-year-follow-up-of-swedish-men-between-1970-and-2011","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2019\/07\/cannabis-use-and-incidence-of-testicular-cancer-a-42-year-follow-up-of-swedish-men-between-1970-and-2011\/","title":{"rendered":"Cannabis Use And Incidence Of Testicular Cancer: A 42-Year Follow-up Of Swedish Men Between 1970 And 2011"},"content":{"rendered":"<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\">Abstract<\/span><\/p>\n<p id=\"p-2\" style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><strong>Background:<\/strong>\u00a0Given current drug policy reforms to decriminalize or legalize cannabis in numerous countries worldwide, the current study assesses the relation between cannabis use and the development of testicular cancer.<\/span><\/p>\n<p id=\"p-3\" style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><strong>Methods:<\/strong>\u00a0The study included a population-based sample (<em>n<\/em>\u00a0= 49,343) of young men ages 18\u201321 years who underwent conscription assessment for Swedish military service in 1969\u20131970. The conscription process included a nonanonymous questionnaire eliciting information about drug use. Conscription information was linked to Swedish health and administrative registry data. Testicular cancers diagnosed between 1970 and 2011 were identified by International Classification of Diseases-7\/8\/9\/10 testicular cancer codes in the Swedish National Patient Register, the Cancer Register, or the Cause of Death Register. Cox regression modeling was used to estimate the hazards associated with cannabis use and time to diagnosis of testicular cancer.<\/span><\/p>\n<p id=\"p-4\" style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><strong>Results:<\/strong>\u00a0No evidence was found of a significant relation between lifetime \u201cever\u201d cannabis use and the subsequent development of testicular cancer [<em>n<\/em>\u00a0= 45,250; 119 testicular cancer cases; adjusted HR (aHR), 1.42; 95% confidence interval (CI), 0.83\u20132.45]. \u201cHeavy\u201d cannabis use (defined as usage of more than 50 times in lifetime, as measured at conscription) was associated with the incidence of testicular cancer (<em>n<\/em>\u00a0= 45,250; 119 testicular cancer cases; aHR 2.57; 95% CI, 1.02\u20136.50).<\/span><\/p>\n<p id=\"p-5\" style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><strong>Conclusions:<\/strong>\u00a0The current study provides additional evidence to the limited prior literature suggesting cannabis use may contribute to the development of testicular cancer.<\/span><\/p>\n<p id=\"p-6\" style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><strong>Impact:<\/strong>\u00a0Emerging changes to cannabis drug policy should consider the potential role of cannabis use in the development of testicular cancer.\u00a0<em>Cancer Epidemiol Biomarkers Prev; 26(11); 1644\u201352. \u00a92017 AACR<\/em>.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\">Source: <a style=\"color: #0000ff\" href=\"http:\/\/cebp.aacrjournals.org\/content\/26\/11\/1644\">http:\/\/cebp.aacrjournals.org\/content\/26\/11\/1644<\/a> November 2017<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abstract Background:\u00a0Given current drug policy reforms to decriminalize or legalize cannabis in numerous countries worldwide, the current study assesses the relation between cannabis use and the development of testicular cancer. Methods:\u00a0The study included a population-based sample (n\u00a0= 49,343) of young men ages 18\u201321 years who underwent conscription assessment for Swedish military service in 1969\u20131970. The [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30,64],"tags":[],"class_list":["post-15511","post","type-post","status-publish","format-standard","hentry","category-cannabis-marijuana","category-health"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/15511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=15511"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/15511\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=15511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=15511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=15511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}